202 related articles for article (PubMed ID: 25219592)
21. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma.
Pistollato F; Abbadi S; Rampazzo E; Viola G; Della Puppa A; Cavallini L; Frasson C; Persano L; Panchision DM; Basso G
Biochem Pharmacol; 2010 Nov; 80(10):1517-27. PubMed ID: 20705058
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the Warburg effect in early-passage breast cancer cells.
Robey IF; Stephen RM; Brown KS; Baggett BK; Gatenby RA; Gillies RJ
Neoplasia; 2008 Aug; 10(8):745-56. PubMed ID: 18670636
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
26. Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells.
Kaushik N; Lee SJ; Choi TG; Baik KY; Uhm HS; Kim CH; Kaushik NK; Choi EH
Sci Rep; 2015 Mar; 5():8726. PubMed ID: 25735798
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase D1 regulates hypoxic metabolism through HIF-1α and glycolytic enzymes incancer cells.
Chen J; Cui B; Fan Y; Li X; Li Q; Du Y; Feng Y; Zhang P
Oncol Rep; 2018 Aug; 40(2):1073-1082. PubMed ID: 29901206
[TBL] [Abstract][Full Text] [Related]
28. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma.
Nakajima K; Kawashima I; Koshiisi M; Kumagai T; Suzuki M; Suzuki J; Mitsumori T; Kirito K
Exp Hematol; 2019 Oct; 78():46-55.e3. PubMed ID: 31560931
[TBL] [Abstract][Full Text] [Related]
29. Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis.
Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
Tumour Biol; 2016 Sep; 37(9):12347-12358. PubMed ID: 27306214
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
31. TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.
Remels AH; Gosker HR; Verhees KJ; Langen RC; Schols AM
Endocrinology; 2015 May; 156(5):1770-81. PubMed ID: 25710281
[TBL] [Abstract][Full Text] [Related]
32. Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols.
Hong KS; Park JI; Kim MJ; Kim HB; Lee JW; Dao TT; Oh WK; Kang CD; Kim SH
Toxicol Appl Pharmacol; 2012 Mar; 259(2):210-8. PubMed ID: 22245592
[TBL] [Abstract][Full Text] [Related]
33. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M
Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290
[TBL] [Abstract][Full Text] [Related]
35. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
36. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.
Koshiji M; Kageyama Y; Pete EA; Horikawa I; Barrett JC; Huang LE
EMBO J; 2004 May; 23(9):1949-56. PubMed ID: 15071503
[TBL] [Abstract][Full Text] [Related]
37. Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.
Huang SW; Kao JK; Wu CY; Wang ST; Lee HC; Liang SM; Chen YJ; Shieh JJ
Oncotarget; 2014 Mar; 5(5):1363-81. PubMed ID: 24658058
[TBL] [Abstract][Full Text] [Related]
38. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
Kumar S; Donti TR; Agnihotri N; Mehta K
Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
